Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Wednesday, February 22, 2012

Resigned J&J CEO Weldon on "halo" effect of baby products/medical devices marketing

LINK HERE: Forbes story: J&J baby medicine "halo effect" for failed hips, defibrillators, stents

Under the cover of a respected purveyor of baby products is an aggressive and very profitable medical device industry.
When the  priority of a business entity selling implantable medical devices is solely profit  there must be regulation and judicial accountability to provide for patient safety.

No comments:

Post a Comment